Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析

◆英語タイトル:Pacira BioSciences Inc (PCRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1642
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Pacira BioSciences Inc (PCRX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pacira BioSciences Inc (Pacira), formerly Pacira Pharmaceuticals Inc, provides non-opioid pain management and regenerative health solutions. The company develops drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic administered at the time of surgery to control pain and eliminate the use of opioids for acute postsurgical pain. Its other products include iovera, an non-opioid treatment intended to block pain, pain relief and symptoms related with osteoarthritis of the knee; among others. Its products are essentially used by hospitals, doctors and ambulatory surgery centers. The company sells products through co-promotion agreements and supply agreements with other pharmaceutical companies. Pacira is headquartered in Parsippany, New Jersey, the US.

Pacira BioSciences Inc Key Recent Developments

Feb 20,2020 Pacira reports record fourth quarter and full-year revenues
Jan 10,2020 Pacira BioSciences: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jan 09,2020 Pacira BioSciences reports full-year 2019 preliminary revenue of $421.0 million
Nov 07,2019 Pacira BioSciences reports third quarter 2019 financial results and business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Pacira BioSciences Inc – Key Facts
Pacira BioSciences Inc – Key Employees
Pacira BioSciences Inc – Key Employee Biographies
Pacira BioSciences Inc – Major Products and Services
Pacira BioSciences Inc – History
Pacira BioSciences Inc – Company Statement
Pacira BioSciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Pacira BioSciences Inc – Business Description
Product Category: Bupivacaine liposome injectable suspension
Performance
Product Category: Exparel
Overview
Performance
R&D Overview
Pacira BioSciences Inc – Corporate Strategy
Pacira BioSciences Inc – SWOT Analysis
SWOT Analysis – Overview
Pacira BioSciences Inc – Strengths
Pacira BioSciences Inc – Weaknesses
Pacira BioSciences Inc – Opportunities
Pacira BioSciences Inc – Threats
Pacira BioSciences Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Pacira BioSciences Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 20, 2020: Pacira reports record fourth quarter and full-year revenues
Jan 10, 2020: Pacira BioSciences: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jan 09, 2020: Pacira BioSciences reports full-year 2019 preliminary revenue of $421.0 million
Nov 07, 2019: Pacira BioSciences reports third quarter 2019 financial results and business update
Sep 19, 2019: Pacira BioSciences appoints Chris Christie to board of directors
Aug 08, 2019: Pacira BioSciences reports second quarter 2019 financial results and business update
Jun 19, 2019: Pacira BioSciences appoints former Johnson & Johnson Executive, Max Reinhardt, as President
May 02, 2019: Pacira BioSciences reports first quarter 2019 revenues of $91.3 million
Mar 06, 2019: Pacira to acquire medical device maker Myoscience for $220m
Feb 28, 2019: Pacira reports record fourth quarter and full year revenues
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Pacira BioSciences Inc, Key Facts
Pacira BioSciences Inc, Key Employees
Pacira BioSciences Inc, Key Employee Biographies
Pacira BioSciences Inc, Major Products and Services
Pacira BioSciences Inc, History
Pacira BioSciences Inc, Other Locations
Pacira BioSciences Inc, Subsidiaries
Pacira BioSciences Inc, Key Competitors
Pacira BioSciences Inc, Ratios based on current share price
Pacira BioSciences Inc, Annual Ratios
Pacira BioSciences Inc, Annual Ratios (Cont...1)
Pacira BioSciences Inc, Annual Ratios (Cont...2)
Pacira BioSciences Inc, Interim Ratios
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Pacira BioSciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Pacira BioSciences Inc, Performance Chart (2015 - 2019)
Pacira BioSciences Inc, Ratio Charts
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Pacira BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Pacira BioSciences Inc (PCRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PT Tempo Scan Pacific Tbk (TSPC):企業の財務・戦略的SWOT分析
    PT Tempo Scan Pacific Tbk (TSPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • First Asset Investment Management Inc:企業の戦略的SWOT分析
    First Asset Investment Management Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • QuantuMDx Group Ltd:医療機器:M&Aディール及び事業提携情報
    Summary QuantuMDx Group Ltd (QuantuMDx) is a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious dise …
  • Qualyst Transporter Solutions LLC-医療機器分野:企業M&A・提携分析
    Summary Qualyst Transporter Solutions LLC (Qualyst Transporter Solutions), formerly Qualyst Inc is a provider of hepatic drug transporter products and contract research services using B-CLEAR technology. The company offers products such as transporter certified products, transporter interactions, he …
  • Genisphere LLC-医療機器分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • Punch Taverns Plc:企業のM&A・事業提携・投資動向
    Punch Taverns Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Punch Taverns Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ameren Corp (AEE):企業の財務・戦略的SWOT分析
    Ameren Corp (AEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Methanol Chemicals Co (2001):企業の財務・戦略的SWOT分析
    Methanol Chemicals Co (2001) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Suelopetrol CA SACA:企業の戦略的SWOT分析
    Suelopetrol CA SACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Aecon Group Inc (ARE):企業の財務・戦略的SWOT分析
    Aecon Group Inc (ARE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Grainger Plc (GRI):企業の財務・戦略的SWOT分析
    Grainger Plc (GRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Meridian Energy Ltd (MEL):電力:M&Aディール及び事業提携情報
    Summary Meridian Energy Ltd (Meridian Energy) is a state-owned energy utility that generates, trades and retails electricity. It utilizes renewable energy sources such as wind and water for generation of electricity. It also procures electricity from the wholesale electricity market. The company sup …
  • Awarepoint Corp-医療機器分野:企業M&A・提携分析
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that offers real time location system. The company provides technology, software and managed services. It offers location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patient …
  • Ramaco Resources Inc. (METC):企業の財務・戦略的SWOT分析
    Ramaco Resources Inc. (METC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • International Speedway Corporation:企業の戦略・SWOT・財務分析
    International Speedway Corporation - Strategy, SWOT and Corporate Finance Report Summary International Speedway Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • The Kroger Co:戦略・SWOT・企業財務分析
    The Kroger Co - Strategy, SWOT and Corporate Finance Report Summary The Kroger Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Krispy Kreme Doughnuts, Inc.:企業の戦略的SWOT分析
    Krispy Kreme Doughnuts, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Mitsubishi Electric Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Electric Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Electric Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆